890 related articles for article (PubMed ID: 30936548)
1. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation.
Thomas AM; Manghi P; Asnicar F; Pasolli E; Armanini F; Zolfo M; Beghini F; Manara S; Karcher N; Pozzi C; Gandini S; Serrano D; Tarallo S; Francavilla A; Gallo G; Trompetto M; Ferrero G; Mizutani S; Shiroma H; Shiba S; Shibata T; Yachida S; Yamada T; Wirbel J; Schrotz-King P; Ulrich CM; Brenner H; Arumugam M; Bork P; Zeller G; Cordero F; Dias-Neto E; Setubal JC; Tett A; Pardini B; Rescigno M; Waldron L; Naccarati A; Segata N
Nat Med; 2019 Apr; 25(4):667-678. PubMed ID: 30936548
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer.
Wirbel J; Pyl PT; Kartal E; Zych K; Kashani A; Milanese A; Fleck JS; Voigt AY; Palleja A; Ponnudurai R; Sunagawa S; Coelho LP; Schrotz-King P; Vogtmann E; Habermann N; Niméus E; Thomas AM; Manghi P; Gandini S; Serrano D; Mizutani S; Shiroma H; Shiba S; Shibata T; Yachida S; Yamada T; Waldron L; Naccarati A; Segata N; Sinha R; Ulrich CM; Brenner H; Arumugam M; Bork P; Zeller G
Nat Med; 2019 Apr; 25(4):679-689. PubMed ID: 30936547
[TBL] [Abstract][Full Text] [Related]
3. Integrated Analysis of Colorectal Cancer Reveals Cross-Cohort Gut Microbial Signatures and Associated Serum Metabolites.
Gao R; Wu C; Zhu Y; Kong C; Zhu Y; Gao Y; Zhang X; Yang R; Zhong H; Xiong X; Chen C; Xu Q; Qin H
Gastroenterology; 2022 Oct; 163(4):1024-1037.e9. PubMed ID: 35788345
[TBL] [Abstract][Full Text] [Related]
4. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
Yu J; Feng Q; Wong SH; Zhang D; Liang QY; Qin Y; Tang L; Zhao H; Stenvang J; Li Y; Wang X; Xu X; Chen N; Wu WK; Al-Aama J; Nielsen HJ; Kiilerich P; Jensen BA; Yau TO; Lan Z; Jia H; Li J; Xiao L; Lam TY; Ng SC; Cheng AS; Wong VW; Chan FK; Xu X; Yang H; Madsen L; Datz C; Tilg H; Wang J; Brünner N; Kristiansen K; Arumugam M; Sung JJ; Wang J
Gut; 2017 Jan; 66(1):70-78. PubMed ID: 26408641
[TBL] [Abstract][Full Text] [Related]
5. Clustering co-abundant genes identifies components of the gut microbiome that are reproducibly associated with colorectal cancer and inflammatory bowel disease.
Minot SS; Willis AD
Microbiome; 2019 Aug; 7(1):110. PubMed ID: 31370880
[TBL] [Abstract][Full Text] [Related]
6. Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes.
Nakatsu G; Zhou H; Wu WKK; Wong SH; Coker OO; Dai Z; Li X; Szeto CH; Sugimura N; Lam TY; Yu AC; Wang X; Chen Z; Wong MC; Ng SC; Chan MTV; Chan PKS; Chan FKL; Sung JJ; Yu J
Gastroenterology; 2018 Aug; 155(2):529-541.e5. PubMed ID: 29689266
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of fecal viromes demonstrates high diagnostic potential of the gut viral signatures for colorectal cancer and adenoma risk assessment.
Chen F; Li S; Guo R; Song F; Zhang Y; Wang X; Huo X; Lv Q; Ullah H; Wang G; Ma Y; Yan Q; Ma X
J Adv Res; 2023 Jul; 49():103-114. PubMed ID: 36198381
[TBL] [Abstract][Full Text] [Related]
8. Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer.
Kong C; Liang L; Liu G; Du L; Yang Y; Liu J; Shi D; Li X; Ma Y
Gut; 2023 Jun; 72(6):1129-1142. PubMed ID: 35953094
[TBL] [Abstract][Full Text] [Related]
9. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
Avuthu N; Guda C
Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota dysbiosis signature is associated with the colorectal carcinogenesis sequence and improves the diagnosis of colorectal lesions.
Gao R; Wang Z; Li H; Cao Z; Gao Z; Chen H; Zhang X; Pan D; Yang R; Zhong H; Shen R; Yin L; Jia Z; Shen T; Qin N; Hu Z; Qin H
J Gastroenterol Hepatol; 2020 Dec; 35(12):2109-2121. PubMed ID: 32337748
[TBL] [Abstract][Full Text] [Related]
11. Establishing a novel colorectal cancer predictive model based on unique gut microbial single nucleotide variant markers.
Ma C; Chen K; Wang Y; Cen C; Zhai Q; Zhang J
Gut Microbes; 2021; 13(1):1-6. PubMed ID: 33430705
[TBL] [Abstract][Full Text] [Related]
12. Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer.
Gao W; Gao X; Zhu L; Gao S; Sun R; Feng Z; Wu D; Liu Z; Zhu R; Jiao N
Gut Microbes; 2023 Dec; 15(2):2245562. PubMed ID: 37635357
[TBL] [Abstract][Full Text] [Related]
13. Potential of fecal microbiota for early-stage detection of colorectal cancer.
Zeller G; Tap J; Voigt AY; Sunagawa S; Kultima JR; Costea PI; Amiot A; Böhm J; Brunetti F; Habermann N; Hercog R; Koch M; Luciani A; Mende DR; Schneider MA; Schrotz-King P; Tournigand C; Tran Van Nhieu J; Yamada T; Zimmermann J; Benes V; Kloor M; Ulrich CM; von Knebel Doeberitz M; Sobhani I; Bork P
Mol Syst Biol; 2014 Nov; 10(11):766. PubMed ID: 25432777
[TBL] [Abstract][Full Text] [Related]
14. Multi-kingdom microbiota analyses identify bacterial-fungal interactions and biomarkers of colorectal cancer across cohorts.
Liu NN; Jiao N; Tan JC; Wang Z; Wu D; Wang AJ; Chen J; Tao L; Zhou C; Fang W; Cheong IH; Pan W; Liao W; Kozlakidis Z; Heeschen C; Moore GG; Zhu L; Chen X; Zhang G; Zhu R; Wang H
Nat Microbiol; 2022 Feb; 7(2):238-250. PubMed ID: 35087227
[TBL] [Abstract][Full Text] [Related]
15. Establishing high-accuracy biomarkers for colorectal cancer by comparing fecal microbiomes in patients with healthy families.
Yang J; Li D; Yang Z; Dai W; Feng X; Liu Y; Jiang Y; Li P; Li Y; Tang B; Zhou Q; Qiu C; Zhang C; Xu X; Feng S; Wang D; Wang H; Wang W; Zheng Y; Zhang L; Wang W; Zhou K; Li S; Yu P
Gut Microbes; 2020 Jul; 11(4):918-929. PubMed ID: 31971861
[TBL] [Abstract][Full Text] [Related]
16. Consistent signatures in the human gut microbiome of old- and young-onset colorectal cancer.
Qin Y; Tong X; Mei WJ; Cheng Y; Zou Y; Han K; Yu J; Jie Z; Zhang T; Zhu S; Jin X; Wang J; Yang H; Xu X; Zhong H; Xiao L; Ding PR
Nat Commun; 2024 Apr; 15(1):3396. PubMed ID: 38649355
[TBL] [Abstract][Full Text] [Related]
17. Expanding the Colorectal Cancer Biomarkers Based on the Human Gut Phageome.
Shen S; Huo D; Ma C; Jiang S; Zhang J
Microbiol Spectr; 2021 Dec; 9(3):e0009021. PubMed ID: 34935421
[TBL] [Abstract][Full Text] [Related]
18. Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study.
Nagata N; Nishijima S; Kojima Y; Hisada Y; Imbe K; Miyoshi-Akiyama T; Suda W; Kimura M; Aoki R; Sekine K; Ohsugi M; Miki K; Osawa T; Ueki K; Oka S; Mizokami M; Kartal E; Schmidt TSB; Molina-Montes E; Estudillo L; Malats N; Trebicka J; Kersting S; Langheinrich M; Bork P; Uemura N; Itoi T; Kawai T
Gastroenterology; 2022 Jul; 163(1):222-238. PubMed ID: 35398347
[TBL] [Abstract][Full Text] [Related]
19. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
20. Towards a metagenomics machine learning interpretable model for understanding the transition from adenoma to colorectal cancer.
Casimiro-Soriguer CS; Loucera C; Peña-Chilet M; Dopazo J
Sci Rep; 2022 Jan; 12(1):450. PubMed ID: 35013454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
